Related Experiment Video
Updated: Jan 23, 2026

Using an Automated Hirschberg Test App to Evaluate Ocular Alignment
Published on: March 24, 2020
Evaluating Reach, Acceptability, Utility, and Engagement with An App-Based Intervention to Improve Medication
Karla Santo1,2, Anna Singleton3, Clara K Chow4,5,6
1Westmead Applied Research Centre, Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2145, Australia. ksanto@georgeinstitute.org.au.
Insights
Medication reminder apps for coronary heart disease (CHD) patients were found to be useful and well-accepted. Young male patients with CHD were more likely to use these apps, which improved medication adherence.
Area of Science:
- Digital health interventions
- Cardiovascular disease management
- Medication adherence research
Background:
- Improving medication adherence is crucial for managing Coronary Heart Disease (CHD).
- Mobile applications offer a potential tool to enhance adherence.
- The MEDication reminder APPlications (MedApp-CHD) study evaluated app-based interventions for CHD patients.
Purpose of the Study:
- To assess the reach, acceptability, utility, and engagement of medication reminder apps in the MedApp-CHD study.
- To understand patient experiences with digital tools for medication adherence.
- To identify key features that promote app usage and adherence in CHD patients.
Main Methods:
- A mixed-methods approach was employed in the randomized clinical trial.
- Data collected from patient screening logs, three-month follow-up questionnaires, focus groups, and app software analytics.
- 163 CHD patients were randomized into usual care, basic app, or advanced app groups.
Main Results:
- High completion rates for feedback questionnaires (94%) and focus group participation.
- Participants found apps useful for medication reminders and accessible medication lists.
- Apps were likely to be continued post-study and recommended to others.
- Clinical measurement features were useful for tracking blood pressure and glucose, particularly for those with diabetes/hypertension.
- Medication-related features were used more than clinical measurement features.
- Lack of suitable smartphones was a primary exclusion reason, particularly among older females.
Conclusions:
- Medication reminder apps are well-accepted and useful for improving medication adherence in CHD patients.
- Younger male patients with CHD show higher engagement with these apps.
- Key app features include timely reminders and accessible medication lists.
- Future digital health interventions should consider smartphone accessibility and user demographics.
Objective:
The aim of this study was to assess the reach, acceptability, utility, and engagement with the apps that were used in the MEDication reminder APPlications (apps) to improve medication adherence in Coronary Heart Disease (MedApp-CHD) study, a randomised clinical trial to improve medication adherence, using a mixed-methods approach.
Methods:
The MedApp-CHD study randomised 163 patients with coronary heart disease (CHD) to one of three groups: (i) usual care (n = 56), (ii) a basic medication reminder app (n = 54), or (iii) an advanced medication reminder app (n = 53). For this mixed-methods evaluation, the data sources included patient screening logs, feedback questionnaires collected at three-month follow-up, focus groups discussions, and analytical data from the app software.
Results:
Ninety-four percent (98/104) of participants who received a medication reminder app completed the three-month feedback questionnaire and 15 participated in the focus group discussions. The themes that were identified included that participants (i) found the medication reminders useful in reminding them to take the medications on the correct time every day, (ii) liked having the medication list as an easily-accessible record of medications' names and dosages, (iii) reported being likely to continue to use the apps after the study completion, (iv) would be likely to recommend the apps to their family and friends, and (v) those who used the clinical measurements feature found it useful as a tool to track and graph the blood pressure and glucose levels over time (especially those with diabetes and/or hypertension). In addition, analytical data from the app software demonstrated that the participants used the medication-related features more than the clinical measurements feature. Furthermore, data from the patient screening logs showed that the main reason for exclusion, other than not meeting the CHD criteria, was not having a suitable smartphone, and those that were excluded for this reason were older and had a higher proportion of females than those enrolled in the study.
Conclusion:
This study provides important insights regarding the features that are most useful in apps that aim to improve medication adherence. This mixed-methods evaluation suggests that, currently, young male patients with CHD are more likely to use such apps, that the apps were well-accepted and useful in reminding the patients to take the medications, and that the patients were engaged in regularly using the apps.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Heart Failure IV: Classification and Diagnostic Evaluation
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Self-Evaluation: Self-Enhancement and Self-Verification

